CLDF Title
Home | Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Conference Highlights

Live CME Meetings

Beginning Date


Ending Date




Target Audience

The target audience will include gastroenterologists, hepatologists, nurse practitioners and physician assistants treating CLD and cirrhosis patients.

Statement of Need

This series of 25 meetings will provide interactive lectures on the evolving management of CLD and cirrhosis to 375 community gastroenterologists and hepatologists. The series also will focus on emerging treatment updates and review current treatment guidelines.

Educational Objectives

Upon completion of this activity, the participants should be bettert able to:

  • Summarize current best practice in who to screen and most appropriate screening/diagnostics for CLD and thrombocytopenia.
  • Explain the pathophysiology in CLD responsible for thrombocytopenia.
  • Describe moderate and severe thrombocytopenia and their clinical implications.
  • Summarize lab tests to measure bleeding.
  • Describe current standard of care for moderate and severe thrombocytopenic patients undergoing elective procedures.
  • Recognize the risks and benefits of this standard in CLD populations.
  • Explain the role of TPO in thrombogenesis and how recent TPO-based drugs increase platelet count.
  • Physician Accreditation Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

    The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Faculty Disclosure Statement

    All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation have no relationships to disclose.

    Americans with Disabilities Act

    The event staff will be glad to assist you with any special requirements (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-565-5321.

    Accredited by:

    Provided by:

    This activity supported by:

    Educational grant from Dova Pharmaceuticals.

    • Speaker
    • Date
    • Time
    • Venue/Location Information
    Slide Library
    Abstract Library
    Slide Library
    Abstract Library
    Slide Library
    Abstract Library
    Slide Library
    Abstract Library
    Hepatorenal Syndrome
    Slide Library
    Abstract Library
    Slide Library
    Abstract Library
    Slide Library
    Abstract Library
    Slide Library
    About CLDF
    Mission Statement
    Board of Trustees
    Board of Advisors/Faculty
    CLDF Sponsors & Supporters
    Other Resources
    Liver News Library
    Journal Abstracts
    Hep C Link to Care
    Centers of
    Educational Expertise
    Substance Use Disorder
    CLDF Follow Us
      The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
    © Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
    Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.